771 Paclitaxel and carboplatin as adjuvant treatment in high-risk patients with operable non-small cell lung cancer (NSCLC): A feasibility study conducted by the hellenic cooperative oncology group (HeCOG)

✍ Scribed by H. Timotheadou; Ch. Christodoulou; Ch. Papakonstantinou; S. Papadopoulos; J. Skrickova; E. Samantas; P. Papakostas; G. Fountzilas

• Book ID: 118620937
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 169 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90796-8